Toggle light / dark theme

Saving Lives; Changing Minds — Dr. Emanuele Capobianco, MD, Director for Health and Care, International Federation of Red Cross and Red Crescent Societies.


Dr. Emanuele Capobianco, MD, MPH, is the Director for Health and Care at the International Federation of Red Cross and Red Crescent Societies (IFRC), where he leads the IFRC Global Health and Care Team and provides strategic and operational support to 192 National Red Cross and Red Crescent Societies around the world in the areas of community health, emergency health and water/sanitation. He currently also leads the IFRC global response to COVID19 and the IFRC response to the Ebola outbreaks in DRC.

Before this role at IFRC, Dr. Capobianco was the Deputy Executive-Director of The Partnership for Maternal, Newborn & Child Health, a multi-constituency partnership, hosted by the World Health Organization, and is the world’s largest alliance for women’s, children’s and adolescents’ health. He joined there from the Global Fund to Fight AIDS, Tuberculosis and Malaria where he worked as Senior Policy Advisor in the Office of the Executive Director, leading the development of the 2017–2022 Global Fund Strategy.

A study by Monash scientists has found that a rare earth affects the fate of a key reaction with copper, gold, silver, and uranium mineralisation.

The work is part of the “Olympic Dam in a test tube” project, where researchers tried to reproduce the processes that resulted in the concentration of more than a trillion dollars worth of metals at Olympic Dam in South Australia in the laboratory.

The study, published in Nature Communications, found that Cerium, which belongs to the group of elements called ‘rare earths’ speeds up important reactions and plays other significant roles.

Electric stimulation may be able to help blood vessels carry white blood cells and oxygen to wounds, speeding healing, a new study suggests.

The study, published in the Royal Society of Chemistry journal Lab on a Chip, found that steady generates increased permeability across vessels, providing new insight into the ways might grow.

The electrical stimulation provided a constant voltage with an accompanying electric current in the presence of fluid flow. The findings indicate that stimulation increases permeability of the blood vessel—an important characteristic that can help wound-healing substances in the blood reach injuries more efficiently.

As the world fights the SARS-CoV-2 virus causing the COVID-19 pandemic, another group of dangerous pathogens looms in the background. The threat of antibiotic-resistant bacteria has been growing for years and appears to be getting worse. If COVID-19 taught us one thing, it’s that governments should be prepared for more global public health crises, and that includes finding new ways to combat rogue bacteria that are becoming resistant to commonly used drugs.

In contrast to the current pandemic, viruses may be be the heroes of the next epidemic rather than the villains. Scientists have shown that viruses could be great weapons against bacteria that are resistant to antibiotics.

I am a biotechnology and policy expert focused on understanding how personal genetic and biological information can improve human health. Every person interacts intimately with a unique assortment of viruses and bacteria, and by deciphering these complex relationships we can better treat infectious diseases caused by antibiotic-resistant bacteria.

The hematopoietic (blood-forming) stem cells (HSCs) residing in our bone marrow produce all of our blood cells, including key immune cells that protect us from bacteria and viruses. As we age, our HSCs become less efficient and less able to make healthy new blood cells. In a study published online today in Nature, researchers at Albert Einstein College of Medicine have found that this reduction in HSC efficiency is caused in part by the deterioration of chaperone-mediated autophagy (CMA), the housekeeping process that removes damaged proteins and other waste materials that interfere with cells’ ability to function.

“While the aging of HSCs in our bone marrow is inevitable, the good news is that it may be reversible,” said co-study leader Ana Maria Cuervo, M.D., Ph.D., professor of developmental and , of anatomy and structural biology, and of medicine, and the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. “Our studies in mice suggest that drugs we’ve developed at Einstein can activate CMA and potentially restore the vitality of HSCs in older people.”